Vimarsana
Biggest News Aggregation in the World

Nasdaq Agrx News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Nasdaq Agrx. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Nasdaq Agrx Today - Breaking & Trending Today

Head to Head Contrast: Agile Therapeutics (NASDAQ:AGRX) and Indivior (NASDAQ:INDV) - Vimarsana News

Head to Head Contrast: Agile Therapeutics (NASDAQ:AGRX) and Indivior (NASDAQ:INDV)

Agile Therapeutics (NASDAQ:AGRX – Get Free Report) and Indivior (NASDAQ:INDV – Get Free Report) are both medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their earnings, valuation, institutional ownership, risk, profitability, dividends and analyst recommendations. Institutional & Insider Ownership 10.9% of Agile Therapeutics shares […]

Indivior (NASDAQ:INDV) versus Agile Therapeutics (NASDAQ:AGRX) Head to Head Comparison - Vimarsana News

Indivior (NASDAQ:INDV) versus Agile Therapeutics (NASDAQ:AGRX) Head to Head Comparison

Agile Therapeutics (NASDAQ:AGRX – Get Free Report) and Indivior (NASDAQ:INDV – Get Free Report) are both medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their analyst recommendations, valuation, institutional ownership, dividends, earnings, profitability and risk. Profitability This table compares Agile Therapeutics and Indivior’s net […]

Agile Therapeutics (NASDAQ:AGRX) Shares Pass Above 50 Day Moving Average of $2.03 - Vimarsana News

Agile Therapeutics (NASDAQ:AGRX) Shares Pass Above 50 Day Moving Average of $2.03

Agile Therapeutics, Inc. (NASDAQ:AGRX – Get Free Report) shares crossed above its fifty day moving average during trading on Tuesday . The stock has a fifty day moving average of $2.03 and traded as high as $2.03. Agile Therapeutics shares last traded at $1.88, with a volume of 74,942 shares traded. Wall Street Analyst Weigh […]

Agile Therapeutics (NASDAQ:AGRX) Research Coverage Started at StockNews.com - Vimarsana News

Agile Therapeutics (NASDAQ:AGRX) Research Coverage Started at StockNews.com

StockNews.com assumed coverage on shares of Agile Therapeutics (NASDAQ:AGRX – Free Report) in a research report sent to investors on Monday. The brokerage issued a hold rating on the specialty pharmaceutical company’s stock. Separately, Maxim Group raised Agile Therapeutics from a hold rating to a buy rating and set a $5.00 target price on the […]

Agile Therapeutics (NASDAQ:AGRX) Coverage Initiated by Analysts at StockNews.com - Vimarsana News

Agile Therapeutics (NASDAQ:AGRX) Coverage Initiated by Analysts at StockNews.com

StockNews.com assumed coverage on shares of Agile Therapeutics (NASDAQ:AGRX – Free Report) in a research report released on Sunday morning. The firm issued a hold rating on the specialty pharmaceutical company’s stock. Separately, Maxim Group upgraded Agile Therapeutics from a hold rating to a buy rating and set a $5.00 price target for the company […]

Source: wkrb13.com